BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1803 related articles for article (PubMed ID: 20442654)

  • 21. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming.
    Li W; Ding S
    Trends Pharmacol Sci; 2010 Jan; 31(1):36-45. PubMed ID: 19896224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC.
    Aoki T; Ohnishi H; Oda Y; Tadokoro M; Sasao M; Kato H; Hattori K; Ohgushi H
    Tissue Eng Part A; 2010 Jul; 16(7):2197-206. PubMed ID: 20146561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An introduction to induced pluripotent stem cells.
    Hanley J; Rastegarlari G; Nathwani AC
    Br J Haematol; 2010 Oct; 151(1):16-24. PubMed ID: 20666774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining pluripotent stem cells through quantitative proteomic analysis.
    Reiland S; Salekdeh GH; Krijgsveld J
    Expert Rev Proteomics; 2011 Feb; 8(1):29-42. PubMed ID: 21329426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concise review: The magic act of generating induced pluripotent stem cells: many rabbits in the hat.
    Mostoslavsky G
    Stem Cells; 2012 Jan; 30(1):28-32. PubMed ID: 21948613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of pluripotent stem cells from adult mouse liver and stomach cells.
    Aoi T; Yae K; Nakagawa M; Ichisaka T; Okita K; Takahashi K; Chiba T; Yamanaka S
    Science; 2008 Aug; 321(5889):699-702. PubMed ID: 18276851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. iPSC technology: platform for drug discovery. Point.
    Ellis J; Bhatia M
    Clin Pharmacol Ther; 2011 May; 89(5):639-41. PubMed ID: 21512521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concise review: alchemy of biology: generating desired cell types from abundant and accessible cells.
    Pournasr B; Khaloughi K; Salekdeh GH; Totonchi M; Shahbazi E; Baharvand H
    Stem Cells; 2011 Dec; 29(12):1933-41. PubMed ID: 21997905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of novel rat and human pluripotent stem cells by reprogramming and chemical approaches.
    Li W; Ding S
    Methods Mol Biol; 2010; 636():293-300. PubMed ID: 20336530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of 'stemness' and stem cell differentiation by microRNAs.
    Sartipy P; Olsson B; Hyllner J; Synnergren J
    IDrugs; 2009 Aug; 12(8):492-6. PubMed ID: 19629883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Induced pluripotent stem cells generated from reprogramming differentiated cells by defined factors].
    Xia X; Chu J; Chen X
    Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1121-7. PubMed ID: 18837383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Returning to the stem state: epigenetics of recapitulating pre-differentiation chromatin structure.
    Shafa M; Krawetz R; Rancourt DE
    Bioessays; 2010 Sep; 32(9):791-9. PubMed ID: 20652894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of induced pluripotent stem cell lines from human fibroblasts via retroviral gene transfer.
    Miller JD; Schlaeger TM
    Methods Mol Biol; 2011; 767():55-65. PubMed ID: 21822867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced adult stem (iAS) cells and induced transit amplifying progenitor (iTAP) cells-a possible alternative to induced pluripotent stem (iPS) cells?
    Heng BC; Richards M; Ge Z; Shu Y
    J Tissue Eng Regen Med; 2010 Feb; 4(2):159-62. PubMed ID: 19967742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agitation can induce differentiation of human pluripotent stem cells in microcarrier cultures.
    Leung HW; Chen A; Choo AB; Reuveny S; Oh SK
    Tissue Eng Part C Methods; 2011 Feb; 17(2):165-72. PubMed ID: 20698747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 91.